First Clinical Trial for Potential COVID-19 Vaccine Approved in Germany

First Clinical Trial for Potential COVID-19 Vaccine Approved in Germany

TEHRAN (Press Shia Agency) – The first clinical trial of a potential vaccine for the novel coronavirus has been sanctioned in Germany. - World news - The country’s Paul-Ehrlich-Institut (PEI) regulatory body has authorized it as the result of “careful assessment of the potential risk/benefit profile of the vaccine candidate,” the medical institute said in a statement on Wednesday, RT...